New RAS-Mutant Pancreatic Adenocarcinoma With Combined BRAF and MEK Inhibition for Metastatic Melanoma

被引：24

作者：

Carlino, Matteo S. ^{[1
,2
,3
]}

Kwan, Vu ^{[3
]}

Miller, David K. ^{[4
,5
]}

Saunders, Catherine A. B. ^{[3
]}

Yip, Desmond ^{[6
,7
]}

Nagrial, Adnan M. ^{[8
]}

Tomlinson, Jeanne ^{[3
]}

Grimmond, Sean M. ^{[4
,5
]}

Scolyer, Richard A. ^{[9
,10
]}

Kefford, Richard F. ^{[1
,2
,3
,9
]}

Biankin, Andrew V. ^{[8
,11
,12
,13
]}

Long, Georgina V. ^{[9
,14
,15
]}

机构：

[1] Univ Sydney Westmead, Westmead Inst Canc Res, Sydney, NSW, Australia

[2] Millennium Inst, Sydney, NSW, Australia

[3] Westmead Hosp, Sydney, NSW, Australia

[4] Queensland Ctr Med Genom, Brisbane, Qld, Australia

[5] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia

[6] Canberra Hosp, Canberra, ACT, Australia

[7] Australian Natl Univ, Sch Med, Canberra, ACT, Australia

[8] Kinghorn Canc Ctr, Garvan Inst Med Res, Sydney, NSW, Australia

[9] Melanoma Inst Australia, Sydney, NSW, Australia

[10] Royal Prince Alfred Hosp, Sydney, NSW, Australia

[11] Univ New S Wales, South Western Sydney Clin Sch, Liverpool, Merseyside, England

[12] Univ Glasgow, Inst Canc Sci, Wolfson Wohl Canc Res Ctr, Glasgow, Lanark, Scotland

[13] Glasgow Royal Infirm, Glasgow G4 0SF, Lanark, Scotland

[14] Univ Sydney, Sydney, NSW 2006, Australia

[15] Westmead Inst Canc Res, Sydney, NSW, Australia

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 11期

基金：

英国惠康基金;

关键词：

IMPROVED SURVIVAL; PROGRESSION; VEMURAFENIB; MUTATIONS;

D O I：

10.1200/JCO.2013.51.5783

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：E52 / E56

页数：5

共 17 条

[1] BRAF Inhibitor-Driven Tumor Proliferation in a KRAS-Mutated Colon Carcinoma Is Not Overcome by MEK1/2 Inhibition [J].

Andrews, Miles C. ;

Behren, Andreas ;

Chionh, Fiona ;

Mariadason, John ;

Vella, Laura J. ;

Do, Hongdo ;

Dobrovic, Alexander ;

Tebbutt, Niall ;

Cebon, Jonathan .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (35) :E448-E451

[2] Cutaneous toxicities of RAF inhibitors [J].

Anforth, Rachael ;

Fernandez-Penas, Pablo ;

Long, Georgina V. .

LANCET ONCOLOGY, 2013, 14 (01) :E11-E18

[3] Final Version of 2009 AJCC Melanoma Staging and Classification [J].

Balch, Charles M. ;

Gershenwald, Jeffrey E. ;

Soong, Seng-jaw ;

Thompson, John F. ;

Atkins, Michael B. ;

Byrd, David R. ;

Buzaid, Antonio C. ;

Cochran, Alistair J. ;

Coit, Daniel G. ;

Ding, Shouluan ;

Eggermont, Alexander M. ;

Flaherty, Keith T. ;

Gimotty, Phyllis A. ;

Kirkwood, John M. ;

McMasters, Kelly M. ;

Mihm, Martin C., Jr. ;

Morton, Donald L. ;

Ross, Merrick I. ;

Sober, Arthur J. ;

Sondak, Vernon K. .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (36) :6199-6206

[4] Progression of RAS-Mutant Leukemia during RAF Inhibitor Treatment [J].

Callahan, Margaret K. ;

Rampal, Raajit ;

Harding, James J. ;

Klimek, Virginia M. ;

Chung, Young Rock ;

Merghoub, Taha ;

Wolchok, Jedd D. ;

Solit, David B. ;

Rosen, Neal ;

Abdel-Wahab, Omar ;

Levine, Ross L. ;

Chapman, Paul B. .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (24) :2316-2321

[5]

Chapman P, 2012, SOC MEL RES C LOS AN

[6] Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation [J].

Chapman, Paul B. ;

Hauschild, Axel ;

Robert, Caroline ;

Haanen, John B. ;

Ascierto, Paolo ;

Larkin, James ;

Dummer, Reinhard ;

Garbe, Claus ;

Testori, Alessandro ;

Maio, Michele ;

Hogg, David ;

Lorigan, Paul ;

Lebbe, Celeste ;

Jouary, Thomas ;

Schadendorf, Dirk ;

Ribas, Antoni ;

O'Day, Steven J. ;

Sosman, Jeffrey A. ;

Kirkwood, John M. ;

Eggermont, Alexander M. M. ;

Dreno, Brigitte ;

Nolop, Keith ;

Li, Jiang ;

Nelson, Betty ;

Hou, Jeannie ;

Lee, Richard J. ;

Flaherty, Keith T. ;

McArthur, Grant A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (26) :2507-2516

[7]

Dalle S, 2011, NEW ENGL J MED, V365, P1448, DOI 10.1056/NEJMc1108651

[8] New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) [J].

Eisenhauer, E. A. ;

Therasse, P. ;

Bogaerts, J. ;

Schwartz, L. H. ;

Sargent, D. ;

Ford, R. ;

Dancey, J. ;

Arbuck, S. ;

Gwyther, S. ;

Mooney, M. ;

Rubinstein, L. ;

Shankar, L. ;

Dodd, L. ;

Kaplan, R. ;

Lacombe, D. ;

Verweij, J. .

EUROPEAN JOURNAL OF CANCER, 2009, 45 (02) :228-247

[9] Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations [J].

Flaherty, Keith T. ;

Infante, Jeffery R. ;

Daud, Adil ;

Gonzalez, Rene ;

Kefford, Richard F. ;

Sosman, Jeffrey ;

Hamid, Omid ;

Schuchter, Lynn ;

Cebon, Jonathan ;

Ibrahim, Nageatte ;

Kudchadkar, Ragini ;

Burris, Howard A., III ;

Falchook, Gerald ;

Algazi, Alain ;

Lewis, Karl ;

Long, Georgina V. ;

Puzanov, Igor ;

Lebowitz, Peter ;

Singh, Ajay ;

Little, Shonda ;

Sun, Peng ;

Allred, Alicia ;

Ouellet, Daniele ;

Kim, Kevin B. ;

Patel, Kiran ;

Weber, Jeffrey .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (18) :1694-1703

[10] Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma [J].

Flaherty, Keith T. ;

Robert, Caroline ;

Hersey, Peter ;

Nathan, Paul ;

Garbe, Claus ;

Milhem, Mohammed ;

Demidov, Lev V. ;

Hassel, Jessica C. ;

Rutkowski, Piotr ;

Mohr, Peter ;

Dummer, Reinhard ;

Trefzer, Uwe ;

Larkin, James M. G. ;

Utikal, Jochen ;

Dreno, Brigitte ;

Nyakas, Marta ;

Middleton, Mark R. ;

Becker, Juergen C. ;

Casey, Michelle ;

Sherman, Laurie J. ;

Wu, Frank S. ;

Ouellet, Daniele ;

Martin, Anne-Marie ;

Patel, Kiran ;

Schadendorf, Dirk .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (02) :107-114

← 1 2 →